Anika Therapeutics, Inc (ANIK) insider trading
Every open-market stock purchase and sale by Anika Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Gary P Fischetti (Insider) bought $41.1K in the last 90 days.
Last 12 months: insiders bought $264K (3 buys) and sold $0 (0 sales). Last close $21.09 on Oct 22, 2026.
Recent ANIK insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 4, 2026 | Gary P Fischetti (Insider) | Bought | $20.3K |
| Aug 3, 2026 | Gary P Fischetti (Insider) | Bought | $20.7K |
| Jun 18, 2026 | Sheryl L Conley (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Stephen Richard (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | John B Henneman III (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Joseph H Capper (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Gary P Fischetti (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Stephen D. Griffin (CEO) | Sold (not open market) | $54.3K |
| Jun 3, 2026 | Stephen D. Griffin (CEO) | Bought (not open market) | — |
| May 1, 2026 | John B Henneman III (Insider) | Bought | $73.3K |
| Apr 30, 2026 | Stephen D. Griffin (CEO) | Bought | $150K |
| Mar 19, 2026 | Ian McLeod (C-suite exec) | Bought (not open market) | — |
| Mar 19, 2026 | Ian McLeod (C-suite exec) | Bought (not open market) | — |
| Mar 19, 2026 | Ian McLeod (C-suite exec) | Bought (not open market) | — |
| Mar 15, 2026 | Cheryl R Blanchard (Insider) | Sold (not open market) | $172K |
| Mar 15, 2026 | David Colleran (VP) | Sold (not open market) | $26.9K |
| Mar 15, 2026 | Ian McLeod (C-suite exec) | Sold (not open market) | $11.1K |
| Mar 15, 2026 | Cheryl R Blanchard (Insider) | Bought (not open market) | — |
| Mar 15, 2026 | Ian McLeod (C-suite exec) | Bought (not open market) | — |
| Mar 15, 2026 | David Colleran (VP) | Bought (not open market) | — |
| Mar 14, 2026 | Cheryl R Blanchard (Insider) | Sold (not open market) | $209K |
| Mar 14, 2026 | Stephen D. Griffin (CEO) | Sold (not open market) | $84.4K |
| Mar 14, 2026 | David Colleran (VP) | Sold (not open market) | $59.2K |
| Mar 14, 2026 | Ian McLeod (C-suite exec) | Sold (not open market) | $20.6K |
| Mar 14, 2026 | Ian McLeod (C-suite exec) | Bought (not open market) | — |
Who's trading ANIK
- Gary P Fischetti, Insider: bought $41.1K (2 buys), last Aug 4, 2026
- Stephen Richard, Director: other filings, last Jun 18, 2026
- Joseph H Capper, Director: other filings, last Jun 18, 2026
- John B Henneman III, Director: bought $73.3K (1 buy), last Jun 18, 2026
- Sheryl L Conley, Director: other filings, last Jun 18, 2026
- Stephen D. Griffin, CEO: bought $150K (1 buy), last Jun 3, 2026
- Ian McLeod, C-suite exec: other filings, last Mar 19, 2026
- Cheryl R Blanchard, CEO: other filings, last Mar 15, 2026
- David Colleran, VP: other filings, last Mar 15, 2026
Get free alerts when an insider at Anika Therapeutics, Inc files a new trade →